VITI, VITTORIO
VITI, VITTORIO
Facoltà di Medicina e Chirurgia
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?
2025-01-01 Viti, V.; Zanetta, C.; Rocca, M. A.; Filippi, M.
Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue
2024-01-01 Viti, V.; Zanetta, C.; Capra, R.; Municchi, A.; Rocca, M. A.; Filippi, M.
Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report
2025-01-01 Viti, V.; Cutillo, G.; Rubin, M.; Zanetta, C.; Rocca, M. A.; Filippi, M.
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
2025-01-01 Moiola, L.; Mandelli, A.; Tarkowski, M.; Finardi, A.; Gabrieli, A.; Zanetta, C.; Viti, V.; Gattuso, I.; Esposito, F.; Pedotti, R.; Muros-Le Rouzic, E.; Raposo, C.; Rocca, M. A.; Locatelli, M.; Bonini, C.; Furlan, R.; Riva, A.; Filippi, M.
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis
2025-01-01 Giordano, A.; Giliberti, A.; Clarelli, F.; Misra, K.; Mascia, E.; Sorosina, M.; Visentin, G.; Margoni, M.; Moiola, L.; Rocca, M. A.; Filippi, M.; Esposito, F.; Azzimonti, M.; Colombo, B.; D'Amore, G.; Ferre, L.; Genchi, A.; Guerrieri, S.; Gueye, M.; Gattuso, I.; Preziosa, P.; Rubin, M.; Visentin, G.; Viti, V.; Zaccone, T.; Zanetta, C.
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use
2025-01-01 Guerrieri, Simone; Gattuso, Irene; Genchi, Angela; Nozzolillo, Agostino; Viti, Vittorio; Zanetta, Chiara; D'Amore, Giulia; Rocca, Maria A.; Moiola, Lucia; Filippi, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS? | 1-gen-2025 | Viti, V.; Zanetta, C.; Rocca, M. A.; Filippi, M. | |
| Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue | 1-gen-2024 | Viti, V.; Zanetta, C.; Capra, R.; Municchi, A.; Rocca, M. A.; Filippi, M. | |
| Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report | 1-gen-2025 | Viti, V.; Cutillo, G.; Rubin, M.; Zanetta, C.; Rocca, M. A.; Filippi, M. | |
| Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab | 1-gen-2025 | Moiola, L.; Mandelli, A.; Tarkowski, M.; Finardi, A.; Gabrieli, A.; Zanetta, C.; Viti, V.; Gattuso, I.; Esposito, F.; Pedotti, R.; Muros-Le Rouzic, E.; Raposo, C.; Rocca, M. A.; Locatelli, M.; Bonini, C.; Furlan, R.; Riva, A.; Filippi, M. | |
| Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis | 1-gen-2025 | Giordano, A.; Giliberti, A.; Clarelli, F.; Misra, K.; Mascia, E.; Sorosina, M.; Visentin, G.; Margoni, M.; Moiola, L.; Rocca, M. A.; Filippi, M.; Esposito, F.; Azzimonti, M.; Colombo, B.; D'Amore, G.; Ferre, L.; Genchi, A.; Guerrieri, S.; Gueye, M.; Gattuso, I.; Preziosa, P.; Rubin, M.; Visentin, G.; Viti, V.; Zaccone, T.; Zanetta, C. | |
| Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use | 1-gen-2025 | Guerrieri, Simone; Gattuso, Irene; Genchi, Angela; Nozzolillo, Agostino; Viti, Vittorio; Zanetta, Chiara; D'Amore, Giulia; Rocca, Maria A.; Moiola, Lucia; Filippi, Massimo |